Mark Johnson to Antineoplastic Agents
This is a "connection" page, showing publications Mark Johnson has written about Antineoplastic Agents.
Connection Strength
0.621
-
Mathew EN, Berry BC, Yang HW, Carroll RS, Johnson MD. Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints. Int J Mol Sci. 2022 Feb 02; 23(3).
Score: 0.531
-
Sandberg DI, Peet MM, Johnson MD, Cole P, Koru-Sengul T, Luqman AW. Chemotherapy administration directly into the fourth ventricle in a nonhuman primate model. J Neurosurg Pediatr. 2012 May; 9(5):530-41.
Score: 0.067
-
Low JA, Johnson MD, Bone EA, Dickson RB. The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice. Clin Cancer Res. 1996 Jul; 2(7):1207-14.
Score: 0.023